Scholar Rock Quarterly Cash Flow Statement
NASDAQ: SRRKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
42.19-0.01 (-0.02%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Scholar Rock free cash flow
In the quarter ended Jun 30, 2026, Scholar Rock generated -$70.3 million of operating cash flow and spent $1,000 on capital expenditures. That left free cash flow of -$70.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
Scholar Rock cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -109.90M | -105.51M | -90.97M | -102.22M | -110.03M | -74.72M | -66.45M | -64.48M | -58.51M | -56.85M | -46.13M | -42.36M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 297.00K | 335.00K | 425.00K | 423.00K | 417.00K | 393.00K | 395.00K | 446.00K | 498.00K | 598.00K | 672.00K | 708.00K |
| Stock-Based Compensation | 19.66M | 18.25M | 19.42M | 18.33M | 24.43M | 13.41M | 9.50M | 9.65M | 9.31M | 8.16M | 6.95M | 7.20M |
| Change in Working Capital | 16.49M | 1.56M | -4.49M | 15.49M | 10.06M | -16.05M | 7.82M | 2.80M | 811.00K | -31.00K | 6.21M | 3.76M |
| Operating Cash Flow | -70.31M | -82.10M | -75.50M | -68.92M | -76.94M | -78.67M | -49.51M | -52.45M | -49.20M | -49.78M | -37.35M | -32.27M |
| Capital Expenditures | -1.00K | -68.00K | -32.00K | -84.00K | -215.00K | -271.00K | -22.00K | -31.00K | -22.00K | -23.00K | 0 | 0 |
| Investing Cash Flow | -5.50M | -5.33M | 38.97M | 59.70M | 85.47M | 34.55M | -195.37M | 35.31M | 50.62M | 33.38M | -25.13M | -8.47M |
| Debt Issued | 1.05M | 196.68M | 0 | 0 | 1.00K | 24.67M | — | — | — | — | — | — |
| Debt Repaid | 0 | -103.06M | 0 | 0 | 0 | -25.52M | — | — | — | — | — | — |
| Financing Cash Flow | 83.12M | 193.79M | 73.29M | 144.47M | 6.47M | 4.17M | 346.37M | 166.00K | -33.00K | 6.53M | 96.53M | 280.00K |
| Net Change in Cash | 7.31M | 106.35M | — | 135.25M | 15.00M | -39.95M | 101.49M | -16.98M | 1.39M | -9.88M | 34.05M | -40.47M |
| Free Cash Flow | -70.31M | -82.17M | -75.53M | -69.01M | -77.16M | -78.95M | -49.53M | -52.49M | -49.22M | -49.81M | -37.35M | -32.27M |
This table shows 12 quarterly periods of Scholar Rock's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SRRK's reporting calendar. What is a cash flow statement?